Commercial Services Healthcare Sector

Theriva Biologics

Market Cap: US$2.2m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

AXIM Biotechnologies

Market Cap: US$2.2m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

ReShape Lifesciences

Market Cap: US$2.1m

Provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

Nuformix

Market Cap: UK£1.6m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

TALi Digital

Market Cap: AU$3.3m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.

VG Life Sciences

Market Cap: US$2.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

Megola

Market Cap: US$2.1m

Develops and sells various physical water treatment devices.

Standard Dental Labs

Market Cap: US$2.1m

A dental laboratory company, manufactures dental products in Florida.

Quantumzyme

Market Cap: US$2.1m

Operates as a biotransformation company.

Me Today

Market Cap: NZ$3.5m

Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.

Vectus Biosystems

Market Cap: AU$3.2m

Engages in the medical research and development activities in Australia.

Revitalist Lifestyle and Wellness

Market Cap: CA$2.8m

Operates medical clinics.

Aditxt

Market Cap: US$2.0m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

Agentix

Market Cap: US$2.0m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

Patrys

Market Cap: AU$3.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

NewGenIvf Group

Market Cap: US$2.0m

An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

Careteq

Market Cap: AU$3.1m

A medication management services company for health, aged, and home care sectors worldwide.

ZyVersa Therapeutics

Market Cap: US$2.0m

Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

DXS International

Market Cap: UK£1.4m

A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.

Uscom

Market Cap: AU$3.0m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

OMID Holdings

Market Cap: US$1.9m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

EHAVE

Market Cap: US$1.9m

A healthcare company, develops medical psychedelics and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada.

JRSIS Health Care

Market Cap: US$1.9m

Develops and produces medical technology and equipment in the People’s Republic of China.

Comprehensive Healthcare Systems

Market Cap: CA$2.6m

Provides healthcare administrative software solutions in the United States.

Pangenomic Health

Market Cap: CA$2.6m

Operates as a precision health company.

LiveCare

Market Cap: US$1.8m

Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

Vaccinex

Market Cap: US$1.8m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

Entero Therapeutics

Market Cap: US$1.8m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Blueberries Medical

Market Cap: CA$2.5m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Aspira Women's Health

Market Cap: US$1.8m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

Universe Pharmaceuticals

Market Cap: US$1.8m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China.